Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Compares the volatility characteristics of risk parity against index funds in retirement planning, highlighting stability and risk exposure.
27,630 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
In 2026, nuclear energy climbs back into the spotlight as AI-driven electricity demand surges. This article lays out ...
Investors are focused on a pivotal point in the Iran deal: how verification and enforcement are managed as sanctions ...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
Investors on Wall Street are pouring capital into Ukraine's drone technology, led by Swarmers, signaling a new phase ...
Alphabet and Amazon are issuing investment-grade debt at scale, drawing funds away from U.S. Treasuries. The shift pl...
This morning’s update centers on a massive Zcash exploit found by a security researcher. The flaw may have lingered f...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
A San Diego startup led by a former Navy SEAL is using AI to forge a new path for defense contracting. The move draws...
A record 207 crypto hacks were logged in H1 2026, but total losses fell to $972 million as disruption spreads beyond ...
Investors eye the physical ai’s trillion opportunity—a potential $50 trillion payoff from industrial AI—but it requir...